Pharma Pulse 8/1/24: Addressing the Drug Shortage Crisis, Microsoft’s AI Dreams = An Expensive Reality & more

Addressing the Drug Shortage Crisis

Peter Ax provides insight as to industry’s lack of supply, along with how to mitigate these issues.

St. John’s Wort Could Show Benefit in Major Depressive Disorder

Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.

Microsoft’s AI Dreams Make for an Expensive Reality

As cloud growth disappoints, blowout capital spending won’t hearten investors.

Defining the Health Equity Officer Role: IHI Releases Guidance for Health Systems

New report includes actionable recommendations to support the hiring and long-term success of health equity officers.

Matt Erick on LinkedIn

I recently enjoyed a conversation with Pharmaceutical Executive about the future of the biosimilars market; namely, the therapeutic areas that have the most opportunity for growth and how we can increase access to patients.
#Biosimilars #Access #BioconBiologics

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs